Fluorescite Use In Pregnancy & Lactation





Full Prescribing Info
Use In Pregnancy & Lactation
Fertility: Studies have not been performed to evaluate the effect of intravenous administration of fluorescein on fertility.
Pregnancy: There are insufficient data available concerning the use of Fluorescite Injection 10% during pregnancy. Studies in animals with fluorescein do not indicate harmful effects with respect to reproductive toxicity following systemic administration.
Fluorescein sodium is excreted in human milk following systemic administration for up to 7 days. A risk to the suckling child cannot be excluded. Following fluorescein angiography, breast-feeding should therefore be discontinued for at least 7 days and the milk should be pumped off and discarded during this period.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in